Canagliflozin and Myocardial Fibrosis
NCT05367063
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
45
Enrollment
OTHER
Sponsor class
Conditions
Type 2 Diabetes
Cardiovascular Risk
Interventions
DRUG:
Canagliflozin 100mg or Sitagliptin 100mg
Sponsor
Shanghai Zhongshan Hospital